Announced Tue, 16 Jun · 22:23 IST
Nazara extends timeline for USD 100.3M fund infusion into UK subsidiary
Strategic Transactions View source PDF
NAZARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹301.00
prior close
₹305.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-0.7-1.2-1.6-0.5-1.3-0.2-3.0-3.2+0.9+1.0+1.0——
Up moveDown movePending
AI summary
Nazara Technologies has extended the timeline for infusing up to USD 100.3 million into its wholly owned UK subsidiary, Nazara Technologies UK Limited. The infusion, originally disclosed on March 18, 2026, will be done in one or more tranches via equity subscription (up to USD 40.1M) and a loan (up to USD 60.2M). The new indicative deadline is August 14, 2026, subject to applicable laws.
Likely market impact
Routine procedural update. Delays fund deployment into UK arm but subsidiary remains fully owned. No material impact on shareholders for now.